¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡

News search results
There are '2296' news items matching your search for 'HighLight'

1. Chong Kun Dang Bio obtains patent for improved process for preparing mycophenolate mofetil

Chong Kun Dang Bio recently obtained a Korean patent for ¡®improved process for preparing mycophenolate mofetil¡¯. The patented technology blo ..
 

August 24th, 2010
2. Dong-A, Pfizer Korea and Daewoong record market shares of about 4% each in 1Q 2010

According to the data from IMS Health, Dong-A Pharm occupied 4.37 percent of the pharmaceutical market in the first quarter of 2010, followe ..
 

August 24th, 2010
3. Total output in the bio-industry recorded 14% increase in 2009

The Korea Biotechnology Industry Organization (KOREABIO) selected 100 companies (the top 60 companies in terms of production value, the top ..
 

August 24th, 2010
4. Anticancer drugs, vaccines and antidiabetics account for 42.85% of new drugs launched over the past three years

Analysis of multinational pharmaceutical firms¡¯ 42 new drugs, launched or approved by the KFDA between 2008 and 2010, showed that 6 anticanc ..
 

August 24th, 2010
5. RNL Bio completes a phase I clinical trial for a stem cell-based therapy for the treatment of spinal cord injury

RNL Bio, a local bio-company, completed a phase I clinical trial for RNL-Astrostem, an adult stem cell-based therapy for the treatment of sp ..
 

August 17th, 2010
6. Multinational pharmaceutical firms promoting a strategy to launch new drugs prior to reimbursement listing

Multinational pharmaceutical firms have begun promoting a strategy for launching their new drugs ahead of health insurance reimbursement lis ..
 

August 10th, 2010
7. Takeda Korea expected to operate in September 2010

It is expected that Takeda Pharm, Japan¡¯s largest pharmaceutical firm and the world¡¯s thirteenth-ranking pharmaceutical firm with global s ..
 

August 10th, 2010
8. Guidelines for pharmaceutical equivalence studies concerning post-approval change in manufacturing methods released

The KFDA recently prepared and announced guidelines for ¡®pharmaceutical equivalence studies concerning post-approval change in manufacturing ..
 

August 10th, 2010
9. Korea Green Cross successfully commercializes an albumin-free recombinant coagulation factor VIII

Korea Green Cross recently announced that it received the KFDA approval for GreenGene F inj., a third-generation recombinant coagulation fac ..
 

August 10th, 2010
10. Domestic pharmaceutical firms involved in 13 partnership cases of new drug development with Japanese companies

According to the Korea Drug Research Association (KDRA), domestic pharmaceutical firms are involved in a total of 88 partnership cases with ..
 

June 27th, 2010
11. RNL Bio launches an adult stem cell business unit in China

RNL Bio, a local bio-company, recently held a ceremony to launch an adult stem cell business unit in Shanghai, China. RNL Bio stated that it ..
 

June 27th, 2010
12. Medy-Tox exports a botulinum toxin product to Brazil

Medy-Tox, a local biotechnology company, announced that it made shipment of Meditoxin (Clostridium botulinum type A toxin) inj. worth about ..
 

June 27th, 2010
13. Prices of 133 generic drugs higher than those of the original drugs

According to data submitted to SON Suk-mi, a member of the National Assembly, by the Health Insurance Review Agency (HIRA), the reimbursemen ..
 

June 22nd, 2010
14. Hanall obtains a US patent for an oral formulation of human growth hormone

Hanall Biopharma recently obtained a US patent for ¡®modified growth hormones¡¯. The patent relates to modified growth hormones prepared by us ..
 

June 22nd, 2010
15. Pharmaceutical firms with the fiscal year ending in March hold their regular general meetings of stockholders

Five pharmaceutical firms with the fiscal year ending in March held their regular general meetings of stockholders in May 2010. These firms, ..
 

June 15th, 2010
[1] 2 3 4 5 6 7 8 9 10
¡¡
Pharma Koreana Ltd. 14th floor, KTB Network Bldg., 826-14, Yeoksam, Kangnam-gu, Seoul135-080 ,KOREA Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com
¡¡
¡¡